---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-004941"
form_type: "8-K"
ticker: "CDNA"
cik: "0001217234"
company_name: "CareDx, Inc."
filed_at: "2025-01-13T23:59:59+00:00"
generated_at: "2026-05-28T02:50:55.239227+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# CareDx reports preliminary Q4 revenue up 30% YoY to ~$85.5M; guides 2025 revenue $370M

## Summary
- Q4 revenue expected $85M-$86M, up ~30% YoY; testing services revenue $62.5M-$63.5M, up 35%.
- Full year 2024 revenue $332M-$333M; GAAP loss $58M-$60M; adjusted EBITDA gain $25M-$26M.
- Testing services volume ~45,500 in Q4, up 14% YoY; sixth consecutive quarter of volume growth.
- Cash, equivalents, and marketable securities ~$261M as of Dec 31, 2024, up $26M YoY.
- 2025 revenue guidance of $370M; targeting $500M revenue and 20% adjusted EBITDA by 2027.

## SEC filing metadata
- accession: 0001193125-25-004941
- form_type: 8-K
- ticker: CDNA
- cik: 0001217234
- company_name: CareDx, Inc.
- filed_at: 2025-01-13T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01, 7.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1217234/000119312525004941/0001193125-25-004941-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1217234/000119312525004941/d909876d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-004941
- JSON: https://secwatch.observer/filing/0001193125-25-004941.json
- Plain text: https://secwatch.observer/filing/0001193125-25-004941.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
